AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05814640 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lithium Carbonate
Description: Commonly used oral antipsychotics intervention therapy.
Study NCT05814640 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olanzapine
Description: Commonly used oral antipsychotics intervention therapy.
Study NCT05814640 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: GCBT
Description: Commonly used intervention therapy of psychotherapy.
Study NCT05009485 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Current Health platform
Description: A remote patient monitoring system which includes a small footprint device and tablet, combined with an AI-powered, cloud-based system driving advanced real-time and predictive analytics related to a patient's clinical condition. The wearable records heart rate, respiratory rate, oxygen saturation, skin temperature and step count.
Study NCT06378879 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol 100 MG in 10 ML Injection
Description: Sedation induction time (minutes), total dose of propofol (mg), recovery time (minutes), any involuntary patient movement, quality of sedation (VAS) and adverse events
Study NCT05603026 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Self-expanding valve (Medtronic Evolut FX)
Description: Bioprothesis Medtronic Evolut FX supra-annular self-expanding valve
Study NCT05420727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ga-68-PSMA-11 PET/CT
Description: Ga-68-PSMA-11 PET/CT imaging
Study NCT05420727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu-177-ITG-PSMA-1
Description: Lu-177-ITG-PSMA-1 treatment
Study NCT04769856 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: State-Trait Anxiety Inventory (STAI) scale
Description: State-Trait Anxiety Inventory (STAI) scale
Study NCT04769856 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Satisfaction scale
Description: Satisfaction scale
Study NCT03903601 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic Resonance Imaging (MRI)
Description: Magnetic Resonance Imaging (MRI) to diagnose ischemic changes in the brain.
Study NCT03903601 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood samples collection
Description: Trimethylamine N-oxide (TMAO) concentration, oxidative stress markers and endothelial dysfunction markers will be determined in blood samples.
Study NCT03903601 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Neuropsychological tests
Description: Cognitive functions assessment
Study NCT06671600 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative medicine
Description: osteopathic manipulative treatment protocol will be applied to the cranial, cervical, thoracic, and ribcage regions. OMM procedures performed on the treatment group will consist of 1. suboccipital decompression/release, 2. base spread, 3. occipitoatlantal (OA) decompression, 4. venous sinus drainage, 5. compression of the fourth ventricle, 6. cervical myofascial (unilateral perpendicular stretch), 7. thoracic inlet release (direct or indirect), 8. Bilateral rib raising, 9. thoracoabdominal diaphragm doming (direct technique), and 10. pedal pump (Dalrymple lymphatic pump)
Study NCT04743349 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Steam inhalations
Description: Exposure of airway mucosae to humidified steam through steam inhalation for at least 20 min (4 cycles of 5 min) daily, for 10 days.
Study NCT06448182 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Postbiotic
Description: 1 capsule of postbiotic daily in the morning
Study NCT05603026 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Balloon-expanding valve (Edwards Sapien 3 Ultra)
Description: Bioprosthesis Edwards Sapien 3 Ultra valve
Study NCT06448182 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 capsule of placebo daily in the morning
Study NCT06671600 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham (No Treatment)
Description: The sham group will serve as the control group and will receive a light touch-control procedure based on prior study utilizing light touch.
Study NCT06674096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RLC-CRCHOP
Description: Introduction treatment: Rituximab, lenalidomide, chidamide for 2 cycles:~rituximab 375mg/m2, d1, lenalidomide 10mg qd d1-14, chidamide 20mg, d1,4,8,11.~Immunochemtherapy phase: CR CHOP for 4 cycles: chidamide 20mg d1,4,8,11,rituximab 375mg/m2 d0, cyclophosphamide: 750mg/m2 d1, epirubicin: 75mg/ m2 d1 (or liposomal doxorubicin 35mg/m2 d1), vindesine 4mg d1, prednisone: 100mg, d1-5.~maintenance treatment period: chidamide d1,4,8,11
Study NCT06217536 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lurbinectedin
Description: Given intravenously (IV)
Study NCT06217536 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Conventionally fractionated radiotherapy or external beam radiation
Study NCT05639465 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: JoH-C19
Description: Journey of Hope- COVID 19 (JoH-C19) includes eight, 1-hour consecutive sessions delivered in groups of 8 children during the school day and in after school settings. The 1.5 hour JoH-C19 caregiver workshop is delivered with groups of 8 parents prior to the child JoH-C19 curriculum
Study NCT05639465 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Switch off Get Active
Description: Switch off Get Active covers 4 topics, and its eight, 1- hour sessions are delivered in groups of 8 children. The 1.5 hour Switch Off Get Active caregiver workshop is delivered with groups of 8 parents prior to the Switch off Get Active child curriculum
Study NCT05358015 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: vascularized bone graft for scaphois nonunion
Description: vascularized bone graft for scaphois nonunion
Study NCT05773703 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PSMA-Targeted [In-111]-Labeled Trillium Compound
Description: Radiotracer
Study NCT05773703 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTI-122
Description: Cytoprotective agent
Study NCT05720351 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lachmann maneuver
Description: Patients undergone the Lachmann recruitment maneuver (30 CmH2O PEEP for 30 seconds)
Study NCT05720351 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Staircase maneuver
Description: Patients undergone Undergone staircase recruitment maneuver (stepped increase in PEEP by 2 CmH2O every five breaths until reach upper deflection point
Study NCT06569849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: De-Stress and Focus capsule- U001
Description: Two capsules in sequence daily after meal for 60 days.
Study NCT06569849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: De-Stress and Focus capsule - I001
Description: Two capsules in sequence daily after meal for 60 days.
Study NCT06569849 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsules 001
Description: Two capsules in sequence daily after meal for 60 days.
Study NCT06215157 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Flotrac Group
Description: Haemodynamic parameters were collected simultaneously by the Flotrac monitoring.
Study NCT06215157 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BioZ Group
Description: Haemodynamic parameters were collected simultaneously by the thoracic bioimpedance (BioZ.com™)monitoring.
Study NCT05426083 — intervention group
Intervention type: OTHER
Intervention: Physiological Assessment
Description: Observational only
Study NCT06541587 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mindfulness based virtual reality
Description: mindfulness based virtual reality
Study NCT06541587 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: mindfulness based audio practice
Description: mindfulness based audio practice
Study NCT05613946 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Lumason
Description: Ultrasound microbubble contrast agent intradermal 0.2-0.3 cc of microbubble suspension per injection, 10-12 total injections per upper extremity
Study NCT05613946 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Optison
Description: Ultrasound microbubble contrast agent intradermal 0.2-0.3 cc of microbubble suspension per injection, 10-12 total injections per upper extremity
Study NCT05613946 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Definity
Description: Ultrasound microbubble contrast agent intradermal 0.2-0.3 cc of microbubble suspension per injection, 10-12 total injections per upper extremity
Study NCT05321745 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standardized FMT
Description: Fecal microbiota transplantation of fresh bacteria from healthy donor to the whole colon
Study NCT06332755 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LB-LR1109
Description: intravenous administration
Study NCT04918771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raphamin
Description: Oral administration - not with food. Keep the tablet in the mouth until it is completely dissolved.~On the 1st day of treatment, 8 tablets are taken according to the following scheme: 1 tablet every 30 minutes in the first 2 hours (a total of 5 tablets in 2 hours), then during the same day, take another 1 tablet 3 times at regular intervals. On the 2nd day and then take 1 tablet 3 times a day. The duration of treatment is 5 days.
Study NCT04918771 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral administration - not with food. Placebo using Raphamin scheme.
Study NCT05896826 — intervention group
Intervention type: DEVICE
Intervention: Magnetometer
Description: inspection equipment for magnetocardiography
Study NCT04942470 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aloe vera and propolis applied
Description: Suitable of sterile pads containing aloe vera and propolis to the area with pressure sores
Study NCT06221774 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TT-00420 + Toripalimab
Description: TT-00420 tablets in combination with Toripalimab injection
Study NCT06416085 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: Single high-dose (25mg) capsule of psilocybin taken orally in the context of Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy
Study NCT05356026 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online postpartum follow-up
Description: The women in the experimental group were administered three follow-ups (education/consultancy) in line with the timing and content in the T.R. Ministry of Health Postpartum Care Management Guide (2014). The follow-ups were performed using the Zoom® program, which enabled video talk.
Study NCT05841771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Participants will receive maintenance therapy with venetoclax and azacitidine or decitabine after allogeneic stem cell transplantation.~Azacitidine will be administered once daily subcutaneously (32mg/m2/d) on days 1-5, and venetoclax will be administered once daily orally (400mg/day) on days 1-7. If the patient is refractory or allergic to azacitidine, they will receive decitabine. Decitabine will be administered intravenously (5mg/m2/d) on days 1-5. If the patient is treated with CYP450 inhibitors(such as posaconazole or voriconazole), the dose of venetoclax will reduce to 100 mg once daily on days 1-7. Maintenance therapy will start from the 60th to 120th days after allogeneic hematopoietic stem cell transplantation and repeat every 28 days for up to 10 cycles within the first year after transplantation.
Study NCT05841771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine or decitabine
Description: azacytidine 32mg/m2 or decitabine 5mg/m2
Study NCT06391333 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: laryngeal mask airway and endotracheal tube
Description: The two most commonly used devices for mechanical ventilation.
Study NCT06391333 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: laryngeal mask airway and endotracheal tube
Description: The two most commonly used devices for mechanical ventilation.
Study NCT05281575 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Baby Friendly Spaces (BFS)
Description: Designed to meet the unique needs of populations living in humanitarian contexts, BFS focus on two domains: psychosocial support that targets maternal wellbeing and childcare practices that target caregiver functioning to also address child wellbeing and development. In so doing, BFS strengthens mothers' internal resources and skills in caring for their children both in quantity (time spent caring for the child) and quality (responsiveness), to positively impact the health status and wellbeing of their children. In BFS, the following activities are delivered by trained psychosocial workers: counselling for infant and young child feeding practices; hygiene education and promotion; mother-child bonding activities that provide psychosocial stimulation essential for children at risk of, or experiencing, malnutrition; and provision of maternal psychosocial support (i.e. psychoeducation, stress management).
Study NCT05281575 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Baby Friendly Spaces (BFS)
Description: Designed to meet the unique needs of populations living in humanitarian contexts, BFS focus on two domains: psychosocial support that targets maternal wellbeing and childcare practices that target caregiver functioning to also address child wellbeing and development. In so doing, BFS strengthens mothers' internal resources and skills in caring for their children both in quantity (time spent caring for the child) and quality (responsiveness), to positively impact the health status and wellbeing of their children. In BFS, the following activities are delivered by trained psychosocial workers: counselling for infant and young child feeding practices; hygiene education and promotion; mother-child bonding activities that provide psychosocial stimulation essential for children at risk of, or experiencing, malnutrition; and provision of maternal psychosocial support (i.e. psychoeducation, stress management).
Study NCT05577403 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mulligan's mobilization with movement MWM added isometric strength training
Description: Mulligan's mobilization with movement added isometric exercise:~the participants in the experimental group will receive a Mulligan's mobilization with movement added isometric exercise.~Treatment will be given for the period of three weeks, for five days a week in both groups.~Data will be collected before intervention and after 2nd \& 4th week of intervention.
Study NCT05577403 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mulligan's mobilization with movement MWM added isometric strength training
Description: Mulligan's mobilization with movement added isometric exercise:~the participants in the experimental group will receive a Mulligan's mobilization with movement added isometric exercise.~Treatment will be given for the period of three weeks, for five days a week in both groups.~Data will be collected before intervention and after 2nd \& 4th week of intervention.
Study NCT06498531 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetazolamide
Description: Administration of 1x125mg acetazolamide in the morning, 1x125mg in the evening, starting 24 hours before departure to 3600 m.
Study NCT06498531 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of equally looking placebo capsules in the morning and in the evening, starting 24 hours before departure to 3600 m.
Study NCT05630339 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Magnesium chloride
Description: Each 650 mg capsule contains 340 mg of magnesium chloride, which must be ingested twice a day with aliments.
Study NCT05630339 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D
Description: Each tablet contains 4000 IU of vitamin D, and must be ingested a pill per night.
Study NCT05630339 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Inert placebo
Description: Instead of dietary supplements, sodium bicarbonate as inert placebo will be administered twice a day in 650 mg capsules.
Study NCT00013234 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Teledermatology
Study NCT04996641 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Root canal treatment and crown
Description: Pre-radiation one day root canal treatment and CAD/CAM chair side fabricated crowns for head and neck cancer patients
Study NCT04458194 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: Standard Care is used as a control condition. Cancer survivors assigned to this arm continue to receive standard care from their medical providers.
Study NCT04458194 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: YOCAS©® yoga
Description: Yoga for Cancer Survivors, YOCAS©®, intervention is a low to moderate intensity mode of exercise that draws from two basic types of yoga; gentle Hatha and Restorative yoga. The program includes specific physical postures and mindfulness exercises focused on breathing and meditation. Cancer survivors will participate in 8 virtual YOCAS sessions (75 minutes/session, 2 times a week for 4 weeks) delivered via an electronic platform (e.g., Zoom)
Study NCT05045417 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Serum level of IL-17
Description: Measurement of serum level of IL-17 :~1. To explore the role of IL-17 in systemic lupus erythematosus~2. To determine the relation between IL-17 and lupus disease activity~3. To analyze the correlation between IL-17 and internal organ affection (lupus nephritis , interstitial lung disease)
Study NCT05394350 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1088
Description: Oral Tablet
Study NCT06209372 — intervention group
Intervention type: PROCEDURE
Intervention: Group PENG
Description: Pericapsular Nerve Group Block (PENG)
Study NCT06209372 — intervention group
Intervention type: DRUG
Intervention: Group C
Description: Tramadol infusion
Study NCT05394350 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: IV Infusion
Study NCT05018728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Voxelotor
Description: Voxelotor is taken orally once a day. Participants 12 years or older will take 1500 mg/day. Participants younger than 12 years of age will receive a dose based on their body weight to provide exposure corresponding to the adult dose of 1500 mg/day.
Study NCT05547542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CVL-354
Description: Oral solution/capsule
Study NCT05547542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [11C]-LY2795050
Description: IV injection
Study NCT05547542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [11C]-carfentanil
Description: IV injection
Study NCT05252702 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Aveir DR Leadless Pacemaker System
Description: Patients will undergo a dual chamber leadless pacemaker system implant wherein a leadless pacemaker will be implanted in the right ventricle and right atrium
Study NCT06090591 — intervention group
Intervention type: OTHER
Intervention: SGLT-2 inh therapy, CIED implantation, thromboaspiration,
Description: long-term follow up and observation of patients treated in Cardiology department in the tertiary center and University hospital
Study NCT05049824 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Self Forming Magnetic (SFM) Anastomosis System
Description: The SFM will be placed using an endoscope in the duodenum and laparoscopically into the ileum. A compression anastomosis will be created in each of the subjects and the diversion of enteral flow from the duodenum to ileum will create a metabolic effect that will induce weight loss and impact metabolic disease indicators
Study NCT05073432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Usability of the Discussion Prioritization Tool (DPT) by completing Geriatric Assessment and Conjoint Analysis
Study NCT06290323 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Quadratus lumborum block
Description: Posterior quadratus lumborum block
Study NCT06290323 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Placebo
Description: Patients in the first group are the control group and after spinal anesthesia, the sensory block is formed, the lithotomy position will be taken for the surgical procedure.
Study NCT06536881 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fasting
Description: The dietician will review the patient's chemotherapy schedule, and confirm the fasting window (as windows may be 24, 26 or 48 hours; and chemotherapy start times can vary from patient to patient).
Study NCT06642051 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High Intensity focused ultrasound
Description: Sonablate High Intensity Focused Ultrasound system to ablate incompetent veins of the periphery